Hims Hers $1.2 Billion Global Leap Draws Investor Scrutiny
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
This piece explains how wash sale rules affect Dividend Etf losses, with practical strategies to stay compliant and preserve tax benefits.
20,231 articlesHims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Amazon stock has cooled after a strong run, but bulls argue AI investments, AWS momentum, and ad growth could fuel a ...
With prediction markets signaling a modest chance of beating estimates, Beyond Meat investors are weighing whether th...
Palantir has been one of the most debated names in AI-driven analytics. This deep dive weighs the upside against the ...
NVIDIA's results grabbed headlines, but the stock moved in the opposite direction, sparking a broader market reaction...
In 2025, holdings' 2025 review: from fintech disruptor to banking powerhouse marks a turning point from rapid scale t...
BigBear.AI released its latest quarterly results after the bell, showing a sharp balance-sheet improvement and a path...
A rising AI marketing platform is now available through Reg A+ at $0.85 per share, aiming to become a fresh growth ve...
Unexpected bills hit hard, even for budget-focused savers. This guide explains why having emergency fund beats raidin...
As earnings season winds down, March can be a smart time to add leading tech stocks to your portfolio. Explore three ...
Investors are weighing three very different tech names as AI upgrades drive Nvidia higher while Qualcomm faces a toug...
Blend Labs reports a profitable fourth quarter as a rebound in mortgage activity boosts revenue and renews optimism f...